TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29980545

Group type: EXPERIMENTAL
Intervention: Therapeutic play intervention
Number of subjects: 208

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 208
Study: 26787791

Group type: EXPERIMENTAL
Intervention: Pulsatile flow CPB
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-pulsatile flow CPB
Number of subjects: 40
Study: 25680096

Group type: EXPERIMENTAL
Intervention: Parental support programme (6 months duration) including health information for parents, motivational interviewing, and teacher-led classroom activities.
Number of subjects: 243
Study: 23348870

Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy (RT, n = 21)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Chemoradiation (CRT, n = 21)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Surgery + radiotherapy (SRT, n = 10)
Number of subjects: 52
Study: 20539299

Group type: COMPARATOR
Intervention: Self-help group (SELF)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Moderate physical activity (MOD-PA) 150 min/week
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: High physical activity (HIGH-PA) 300 min/week
Number of subjects: 278

Group type: COMPARATOR
Intervention: Weight-stable (WT-STABLE)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Weight-gain (WT-GAIN)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Weight-loss (WT-LOSS)
Number of subjects: 278
Study: 18387397

Group type: EXPERIMENTAL
Intervention: Sildenafil (100 mg)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study: 17157654

Group type: EXPERIMENTAL
Intervention: Acetone‐precipitated extract containing 0.6 mug Can f 1 per 0.5 mL maintenance dose
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Acetone‐precipitated extract containing 3.0 mug Can f 1 per 0.5 mL maintenance dose
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Acetone‐precipitated extract containing 15.0 mug Can f 1 per 0.5 mL maintenance dose
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 14511168

Group type: EXPERIMENTAL
Intervention: Active treatment (n=10)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (n=12)
Number of subjects: 22
Study: 10575661

Group type: EXPERIMENTAL
Intervention: GLN-antioxidants (40 g/d)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (glycine 40 g/d)
Number of subjects: 26
Study: 8701786

Group type: EXPERIMENTAL
Intervention: Mestranol (80 micrograms/day for 10 days)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Mestranol plus paramethasone (80 micrograms + 6 mg/day for 10 days)
Number of subjects: 13
Study: 1832761

Group type: EXPERIMENTAL
Intervention: rilmenidine 1 mg/day
Number of subjects: 90

Group type: COMPARATOR
Intervention: atenolol 50 mg/day
Number of subjects: 90
Study: 6224685

Group type: EXPERIMENTAL
Intervention: 200 mg norfloxacin twice daily for ten days
Number of subjects: 61

Group type: COMPARATOR
Intervention: 480 mg cotrimoxazole twice daily for ten days
Number of subjects: 61
Study: 31728631

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/day)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 30417614

Group type: EXPERIMENTAL
Intervention: 1 g TXA IV + 1 g TXA IA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1 g TXA IV + 2 g TXA IA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1 g TXA IV + 3 g TXA IA
Number of subjects: 90
Study: 27797693

Group type: EXPERIMENTAL
Intervention: 12-week short message service intervention
Number of subjects: 384
Study: 25026884

Group type: EXPERIMENTAL
Intervention: Phone call intervention
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Non-monetary incentive (scientific book)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 1000
Study: 22142517

Group type: EXPERIMENTAL
Intervention: Higher BMI in women
Number of subjects: 747

Group type: EXPERIMENTAL
Intervention: Higher BMI in men
Number of subjects: 747

Group type: EXPERIMENTAL
Intervention: Eating while doing another activity in men
Number of subjects: 747

Group type: EXPERIMENTAL
Intervention: Eating while doing another activity in women
Number of subjects: 747

Group type: EXPERIMENTAL
Intervention: Fast-food meals in men
Number of subjects: 747
Study: 20357033

Group type: EXPERIMENTAL
Intervention: High physical activity level maintained from T0 to T1
Number of subjects: 435

Group type: COMPARATOR
Intervention: Low physical activity level
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Stable body weight after diagnosis
Number of subjects: 435

Group type: COMPARATOR
Intervention: Weight gain after diagnosis
Number of subjects: 435
Study: 18789826

Group type: EXPERIMENTAL
Intervention: Late wake therapy (LWT) (sleep 21:00-01:00 h)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Early wake therapy (EWT) (sleep 03:00-07:00 h)
Number of subjects: 19
Study: 15655136

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg OD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eprosartan (600 mg OD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12847817

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor-based triple therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: H2-blockers based triple combinations lasting 10-14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Classical triple therapy (bismuth + 2 antimicrobials)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clarithromycin-based therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitroimidazoles-based therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amoxicillin-based therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doxycyclin-based therapies
Number of subjects: 0
Study: 10758085

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjustment for clustering
Number of subjects: 0
Study: 8637342

Group type: EXPERIMENTAL
Intervention: Disulfiram (500 mg orally)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (nothing)
Number of subjects: 20
Study: 1593432

Group type: EXPERIMENTAL
Intervention: IOGEL 1103 capsular bag intraocular lenses
Number of subjects: 200
Study: 2578365

Group type: EXPERIMENTAL
Intervention: Finger movement (unilateral flexion of the index finger)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foot movement (plantar flexion of the foot)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of finger and foot movements
Number of subjects: 20
Study: 31034254

Group type: EXPERIMENTAL
Intervention: High-dose KS drinks
Number of subjects: 134

Group type: COMPARATOR
Intervention: KME drinks
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: KME+CHO drinks
Number of subjects: 134
Study: 28742732

Group type: EXPERIMENTAL
Intervention: Colonoscopy video
Number of subjects: 104

Group type: COMPARATOR
Intervention: GERD video
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Overall correlation
Number of subjects: 104
Study: 26555862

Group type: EXPERIMENTAL
Intervention: Adant® (sodium hyaluronate injection)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Artz® (sodium hyaluronate injection)
Number of subjects: 229
Study: 24760611

Group type: EXPERIMENTAL
Intervention: High intensity resistance training (HighR, 80% 1RM)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low intensity resistance training (LowR, 40% 1RM)
Number of subjects: 17
Study: 22446996

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 3761

Group type: COMPARATOR
Intervention: Pravastatin 40 mg
Number of subjects: 3761
Study: 20155996

Group type: EXPERIMENTAL
Intervention: Hypericum perforatum 900 mg/day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Hypericum perforatum
Number of subjects: 36
Study: 18296545

Group type: EXPERIMENTAL
Intervention: Selective coil occlusion
Number of subjects: 16

Group type: COMPARATOR
Intervention: Therapeutic ICA occlusion
Number of subjects: 16
Study: 15979426

Group type: EXPERIMENTAL
Intervention: Intracoronary aqueous oxygen
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 50
Study: 14764997

Group type: EXPERIMENTAL
Intervention: Tourette syndrome participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched healthy control participants
Number of subjects: 0
Study: 12973385

Group type: EXPERIMENTAL
Intervention: Quetiapine fumarate (Seroquel®)
Number of subjects: 0
Study: 9031875

Group type: EXPERIMENTAL
Intervention: DTaP (diphtheria and tetanus toxoid acellular pertussis vaccine)
Number of subjects: 286

Group type: COMPARATOR
Intervention: DTwP (diphtheria and tetanus toxoid whole-cell pertussis vaccine)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Both DTaP and DTwP
Number of subjects: 286
Study: 1653966

Group type: EXPERIMENTAL
Intervention: Psychosocial complementary programme
Number of subjects: 65
Study: 6427817

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg diazepam
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg diazepam
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg diazepam
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 30776134

Group type: EXPERIMENTAL
Intervention: JNJ-61178104 (0.1, 0.3, 1, 3, and 10 mg/kg IV; 1 mg/kg SC)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: JNJ-61178104 (IV administration)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: JNJ-61178104 (1 mg/kg SC)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: JNJ-61178104 (active treatment)
Number of subjects: 54
Study: 29149379

Group type: EXPERIMENTAL
Intervention: Intratympanic corticosteroids (IT)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Combination therapy (IT plus systemic)
Number of subjects: 112

Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 112
Study: 27386647

Group type: EXPERIMENTAL
Intervention: Tanshinone IIA (T II A) at 80 mg/day for 3 successive days before oxaliplatin chemotherapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (oxaliplatin alone)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Tanshinone IIA (T II A)
Number of subjects: 36
Study: 24471975

Group type: EXPERIMENTAL
Intervention: 4-category response scale mail survey
Number of subjects: 6500

Group type: COMPARATOR
Intervention: 6-category response scale mail survey
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: 4-category response scale telephone survey
Number of subjects: 6500

Group type: COMPARATOR
Intervention: 6-category response scale telephone survey
Number of subjects: 6500

Group type: COMPARATOR
Intervention: 12-page mail survey
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: four-page mail survey
Number of subjects: 6500
Study: 22298793

Group type: COMPARATOR
Intervention: SLE with Therapy (480 patients)
Number of subjects: 555

Group type: COMPARATOR
Intervention: SLE No Therapy (75 patients)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) monotherapy (105 patients)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Prednisone (PRED) ≥20 mg (76 patients)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Immunosuppressor (IS) (95 patients)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: PRED ≥20 mg + IS
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: PRED ≥20 mg + CQ
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: IS + CQ
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: PRED ≥20 mg + IS + CQ
Number of subjects: 555
Study: 19825910

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 22
Study: 17587564

Group type: EXPERIMENTAL
Intervention: oxaliplatin/5‐FU/FA
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5‐FU/FA alone
Number of subjects: 0
Study: 18024208

Group type: EXPERIMENTAL
Intervention: Yoga therapy (supervised training for 10 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine exercises (exercise group for 10 weeks)
Number of subjects: 34
Study: 15005875

Group type: EXPERIMENTAL
Intervention: Granisetron (40 microg kg(‐1)) infused over 3 min
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cimetidine (200 mg, four times a day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Granisetron (40 microg kg(‐1))
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Granisetron with cimetidine
Number of subjects: 12
Study: 11223726

Group type: EXPERIMENTAL
Intervention: Respiratory warm-up (RWU) prior to measurement
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no warm-up)
Number of subjects: 14
Study: 9425399

Group type: EXPERIMENTAL
Intervention: Octreotide (300 micrograms daily for 1 month)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Somatostatin receptor scintigraphy
Number of subjects: 48
Study: 8214737

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.1 mg/kg) followed by placebo (NaCl 0.9%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.1 mg/kg) followed by midazolam (0.1 mg/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo followed by midazolam (0.1 mg/kg)
Number of subjects: 8
Study: 3479443

Group type: EXPERIMENTAL
Intervention: Intraoral approach
Number of subjects: 40

Group type: COMPARATOR
Intervention: Extraoral approach
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 40
Study: 30821897

Group type: EXPERIMENTAL
Intervention: Synbiotic supplement (100 mg Lactobacillus coagulans and fructo‐oligosaccharides, 2 tablets per day for 8 weeks)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Synbiotic supplement
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 28986234

Group type: EXPERIMENTAL
Intervention: BFRE training (4 weeks)
Number of subjects: 9

Group type: COMPARATOR
Intervention: High intensity training (O-HI, 4 weeks at 75% MVC)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High intensity training (Y-BFRE, 4 weeks)
Number of subjects: 9
Study: 24621965

Group type: EXPERIMENTAL
Intervention: Individually tailored telephone counseling
Number of subjects: 193

Group type: COMPARATOR
Intervention: National Cancer Institute brochure
Number of subjects: 193
Study: 24620666

Group type: EXPERIMENTAL
Intervention: Aerobic exercise therapy (40-60 minutes a day, 3-4 days a week)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional symptomatic treatment
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Aerobic exercise therapy
Number of subjects: 32
Study: 21697896

Group type: EXPERIMENTAL
Intervention: Short leukocyte telomere length
Number of subjects: 1271

Group type: EXPERIMENTAL
Intervention: Proportion of short telomeres (shorter than 5 kb)
Number of subjects: 1271

Group type: EXPERIMENTAL
Intervention: Proportion of short telomeres
Number of subjects: 1271
Study: 19782875

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 17868719

Group type: EXPERIMENTAL
Intervention: CAPRA score 0 to 1 group
Number of subjects: 1296

Group type: EXPERIMENTAL
Intervention: CAPRA score 7 or higher group
Number of subjects: 1296

Group type: EXPERIMENTAL
Intervention: CAPRA sum score
Number of subjects: 1296

Group type: EXPERIMENTAL
Intervention: 7-group CAPRA score
Number of subjects: 1296

Group type: EXPERIMENTAL
Intervention: 3-group CAPRA score
Number of subjects: 1296

Group type: EXPERIMENTAL
Intervention: CAPRA score 0 to 1
Number of subjects: 1296

Group type: EXPERIMENTAL
Intervention: CAPRA score 7 to 10
Number of subjects: 1296
Study: 15731536

Group type: EXPERIMENTAL
Intervention: Intravenous nicorandil (Group II)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intravenous isosorbide dinitrate (Group I)
Number of subjects: 200
Study: 12000479

Group type: EXPERIMENTAL
Intervention: Structured parental training program (inter‐disciplinary, educational program covering medical, nutritional, and psychological issues in six group sessions of 2 hours each)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Structured parental training program
Number of subjects: 204

Group type: COMPARATOR
Intervention: Waiting control group (who could participate in the training program 1 year later)
Number of subjects: 204
Study: 9578120

Group type: EXPERIMENTAL
Intervention: Electrocautery ablation of the adenoid
Number of subjects: 24

Group type: COMPARATOR
Intervention: Curettage
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 7659475

Group type: EXPERIMENTAL
Intervention: DTaP vaccines
Number of subjects: 2342

Group type: COMPARATOR
Intervention: Whole-cell vaccine (WCL)
Number of subjects: 2342
Study: 2485347

Group type: EXPERIMENTAL
Intervention: Modified formula of parenteral nutrition
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard formula of parenteral nutrition
Number of subjects: 14
Study: 1173763

Group type: EXPERIMENTAL
Intervention: Iron preparation SA (Eryfer)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iron preparation SC (effervescent tablet)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iron preparation SD (sustained release)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iron preparation SE (enteric-coated pellets)
Number of subjects: 0
Study: 30693966

Group type: EXPERIMENTAL
Intervention: 5-minute breathing (mindfulness) exercise
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no mindfulness exercise)
Number of subjects: 18
Study: 27984823

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCT) 25 mg 1 qd for maximal 7 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo 1 qd for maximal 7 days
Number of subjects: 50
Study: 25456878

Group type: EXPERIMENTAL
Intervention: EuroSCORE II (ESII)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Logistic EuroSCORE (LES)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Society of Thoracic Surgeons Predicted Risk of Mortality (STS‐PROM)
Number of subjects: 304
Study: 23843147

Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 1864

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 1864

Group type: COMPARATOR
Intervention: Reference group (apnea-hypopnea index <15/hour)
Number of subjects: 1864
Study: 21270386

Group type: EXPERIMENTAL
Intervention: High-fat, low-carbohydrate diet (75 ± 1% of calorie intake from fat)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Isocaloric standard diet (23 ± 1% of calorie intake from fat)
Number of subjects: 16
Study: 19255028

Group type: EXPERIMENTAL
Intervention: PURPLE education materials
Number of subjects: 2738
Study: 16616167

Group type: EXPERIMENTAL
Intervention: Barriers to Treatment Inventory (BTI) administered to substance abusers
Number of subjects: 312
Study: 15629765

Group type: EXPERIMENTAL
Intervention: Neuropsychological testing
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Family ratings of motor functioning
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: PET with [18F]FDG
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Motor ratings
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Neuropsychological testing and family ratings of motor functioning
Number of subjects: 64
Study: 11890592

Group type: EXPERIMENTAL
Intervention: Naloxone low dose (LD) - bolus 27 microg/kg; continuous 50 microg/kg/hr
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Naloxone high dose (HD) - bolus 54.5 microg/kg; continuous 100 microg/kg/hr
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 24
Study: 9399710

Group type: EXPERIMENTAL
Intervention: Angina-guided strategy
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: AECG ischemia-guided strategy
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Revascularization strategy
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Medical treatment strategies
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Revascularization group strategy
Number of subjects: 496
Study: 7699476

Group type: EXPERIMENTAL
Intervention: GCNS monitoring with daily patient visits
Number of subjects: 33

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 33
Study: 3109663

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg initially, followed by 4 mg every six hours)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31876883

Group type: EXPERIMENTAL
Intervention: Bovine mesh (experimental group)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Polypropylene mesh (control group)
Number of subjects: 132
Study: 31724348

Group type: EXPERIMENTAL
Intervention: Yinyang Ruyin acupuncture
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Conventional acupuncture
Number of subjects: 180

Group type: COMPARATOR
Intervention: Estazolam (medication group)
Number of subjects: 180
Study: 28336185

Group type: EXPERIMENTAL
Intervention: Self-expanding metallic stent as a bridge to surgery
Number of subjects: 82

Group type: COMPARATOR
Intervention: Emergency surgery
Number of subjects: 82
Study: 26483858

Group type: EXPERIMENTAL
Intervention: DOPS (Direct Observation of Procedural Skills)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Tutor teaching (classical tutor system)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: DOPS
Number of subjects: 193
Study: 23707115

Group type: EXPERIMENTAL
Intervention: AMPAR peptide assay (0.05-0.40 ng/mL for controls, 1.0-8.5 ng/mL for concussions)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: AMPAR peptide values in athletes with multiple concussions (2.0-12.0 ng/mL)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Neurocognitive tests (ImPACT)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (n = 91)
Number of subjects: 124
Study: 21406148

Group type: EXPERIMENTAL
Intervention: NUK pacifier (N; N=73)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Dentistar pacifier (D; N=56)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (C; N=42)
Number of subjects: 129
Study: 19595184

Group type: EXPERIMENTAL
Intervention: Primary hepatic carcinoma group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hepatitis B group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hepatitis B cirrhosis group
Number of subjects: 20
Study: 16491871

Group type: EXPERIMENTAL
Intervention: Viscoat
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Healon
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: HealonV
Number of subjects: 120